Author:
Rosenblatt Alberto,de Campos Guidi Homero Gustavo
Publisher
Springer Berlin Heidelberg
Reference145 articles.
1. Agarwal SS, Sehgal A, Sardana S, Kumar A, Luthra UK (1993) Role of male behavior in cervical carcinogenesis among women with one lifetime sexual partner. Cancer 72: 1666–1669
2. Agosti JM, Goldie SJ (2007) Introducing HPV vaccine in developing countries – key challenges and issues. N Engl J Med 356: 1908–1910
3. Ault KA (2007) Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: A combined analysis of four randomised clinical trials. Lancet 369: 1861–1868
4. Baldwin PJ, van der Burg SH, Boswell CM, Offringa R, Hickling JK, Dobson J, Roberts JS, Latimer JA, Moseley RP, Coleman N, Stanley MA, Sterling JC (2003) Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia. Clin Cancer Res 9: 5205–5213
5. Bierl C, Karem K, Poon AC, Swan D, Tortolero-Luna G, Follen M, Wideroff L, Unger ER, Reeves WC (2005) Correlates of cervical mucosal antibodies to human papillomavirus 16: Results from a case control study. Gynecol Oncol 99: S262–S268